Merrimack Pharmaceuticals logo
Merrimack Pharmaceuticals MACK
$ 15.13 0.0%

Quarterly report 2024-Q1
added 05-15-2024

report update icon

Merrimack Pharmaceuticals Balance Sheet 2011-2024 | MACK

Annual Balance Sheet Merrimack Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - -14 M -16.6 M 46 M -93.4 M 195 M 72 M 84.5 M 46.6 M 2.14 M -50.4 M

Long Term Debt

- - - - - 14.9 M - 217 M 258 M 107 M 103 M 37.5 M -

Long Term Debt Current

- - - - - - - - - 13.3 M 8.25 M - -

Total Non Current Liabilities

- - - - - 14.9 M 1.26 M 244 M 315 M 150 M 178 M 117 M 349 M

Total Current Liabilities

441 K 589 K 562 K 770 K 2.77 M 14.8 M 19.8 M 88.2 M 104 M 111 M 57.7 M 38.5 M -

Total Liabilities

441 K 589 K 562 K 770 K 2.77 M 29.7 M 21 M 333 M 419 M 261 M 236 M 155 M 375 M

Deferred Revenue

- - - - - - - 36.2 M 50.1 M 59.3 M 9.34 M 10.2 M 7.84 M

Retained Earnings

-549 M -548 M -546 M -544 M -541 M -523 M -483 M -955 M -802 M -655 M -572 M -442 M -351 M

Total Assets

19.2 M 19.8 M 14.7 M 16.8 M 20.1 M 88.5 M 117 M 81.5 M 235 M 159 M 192 M 149 M 85.3 M

Cash and Cash Equivalents

5.99 M 19.4 M 14.2 M 14 M 16.6 M 20.1 M 93.4 M 21.5 M 186 M 35.7 M 65.1 M 37.7 M 50.5 M

Book Value

18.7 M 19.2 M 14.2 M 16 M 17.3 M 58.8 M 96.3 M -251 M -184 M -102 M -43.5 M -6.52 M -290 M

Total Shareholders Equity

18.7 M 19.2 M 14.2 M 16 M 17.3 M 58.8 M 96.3 M -251 M -184 M -102 M -43.5 M -6.52 M -290 M

All numbers in USD currency

Quarterly Balance Sheet Merrimack Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - 15 M 15 M 15 M - - - 49.9 M 48.9 M 218 M 217 M 217 M 217 M 217 M 258 M 258 M 258 M 258 M 107 M 107 M 107 M 107 M 103 M 103 M 103 M 103 M 37.5 M - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

22.7 M 441 K 493 K 411 K 463 K 589 K 448 K - 564 K 562 K 683 K 772 K 684 K 770 K 770 K 770 K 770 K 2.77 M 2.77 M 2.77 M 2.77 M 29.7 M 29.7 M 29.7 M 29.7 M 21 M 21 M 21 M 21 M 334 M 334 M 334 M 334 M 419 M 419 M 419 M 419 M 261 M 261 M 261 M 261 M 236 M 236 M 236 M 236 M 155 M 155 M 155 M 155 M 107 M 107 M 107 M 107 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 36.2 M 36.6 M 44.2 M 45.1 M 50.1 M 50.1 M 50.1 M 50.1 M 59.3 M 59.3 M 59.3 M 59.3 M 9.34 M 9.34 M 9.34 M 9.34 M 9.35 M 9.35 M 9.35 M 9.35 M 7.71 M 7.71 M 7.71 M 7.71 M

Retained Earnings

-347 M -549 M -549 M -548 M -548 M -548 M -547 M - -546 M -546 M -546 M -545 M -544 M -544 M -544 M -544 M -544 M -541 M -541 M -541 M -541 M -523 M -523 M -523 M -523 M -483 M -483 M -483 M -483 M -955 M -955 M -955 M -955 M -802 M -802 M -802 M -802 M -655 M -655 M -655 M -655 M -572 M -572 M -572 M -572 M -442 M -442 M -442 M -442 M -351 M -351 M -351 M -351 M

Total Assets

244 M 19.2 M 19.3 M 19.4 M 19.6 M 19.8 M 13.6 M - 14.6 M 14.7 M 15.3 M 15.9 M 16.4 M 16.8 M 16.8 M 16.8 M 16.8 M 20.1 M 20.1 M 20.1 M 20.1 M 88.5 M 88.5 M 88.5 M 88.5 M 117 M 117 M 117 M 117 M 81.5 M 81.5 M 81.5 M 81.5 M 235 M 235 M 235 M 235 M 159 M 159 M 159 M 159 M 192 M 192 M 192 M 192 M 149 M 149 M 149 M 149 M 85.3 M 85.3 M 85.3 M 85.3 M

Cash and Cash Equivalents

234 M 5.99 M 6.08 M 10.1 M 19.4 M 19.4 M 13.1 M 13.4 M 14.3 M 14.2 M 14.6 M 14.9 M 13.9 M 14 M 14 M 14 M 14 M 16.6 M 16.6 M 16.6 M 16.6 M 20.1 M 20.1 M 20.1 M 20.1 M 93.4 M 93.4 M 93.4 M 93.4 M 21.5 M 21.5 M 21.5 M 21.5 M 186 M 186 M 186 M 186 M 35.7 M 35.7 M 35.7 M 35.7 M 65.1 M 65.1 M 65.1 M 65.1 M 37.7 M 37.7 M 37.7 M 37.7 M 50.5 M 50.5 M 50.5 M 50.5 M

Book Value

222 M 18.7 M 18.8 M 19 M 19.2 M 19.2 M 13.2 M - 14.1 M 14.2 M 14.6 M 15.1 M 15.8 M 16 M 16 M 16 M 16 M 17.3 M 17.3 M 17.3 M 17.3 M 58.8 M 58.8 M 58.8 M 58.8 M 96.3 M 96.3 M 96.3 M 96.3 M -253 M -253 M -253 M -253 M -184 M -184 M -184 M -184 M -102 M -102 M -102 M -102 M -43.1 M -43.1 M -43.1 M -43.1 M -6.42 M -6.42 M -6.42 M -6.42 M -21.7 M -21.7 M -21.7 M -21.7 M

Total Shareholders Equity

222 M 18.7 M 18.8 M 19 M 19.2 M 19.2 M 13.2 M 13.6 M 14.1 M 14.2 M 14.6 M 15.1 M 15.8 M 16 M 16 M 16 M 16 M 17.3 M 17.3 M 17.3 M 17.3 M 58.8 M 58.8 M 58.8 M 58.8 M 96.3 M 96.3 M 96.3 M 96.3 M -251 M -251 M -251 M -251 M -184 M -184 M -184 M -184 M -102 M -102 M -102 M -102 M -43.5 M -43.5 M -43.5 M -43.5 M -6.52 M -6.52 M -6.52 M -6.52 M -290 M -290 M - -290 M

All numbers in USD currency